The Tripura State Pharmaceutical Price Monitoring and Resource Unit Office under the Deputy Drugs Controllers organised a pharmacy awareness campaign in Teliamura on Tuesday, November 17 to inform medicine retailers and consumers about substantial cuts in cancer medicine prices.
At A Glance:
-
State Pharmaceutical Price Monitoring and Resource Unit conducted an awareness campaign at medicine shops across Teliamura on November 17.
-
Deputy Drugs Controller Subrata Das said the MRP of certain cancer medicines had fallen by up to 96.45 per cent.
-
The price reductions are expected to save patients around Rs 3,540 crore annually, according to Das.
A special awareness campaign reached medicine shops across Teliamura today evening to inform retailers and consumers about substantial reductions in cancer medicine prices.
The initiative, led by the Tripura State Pharmaceutical Price Monitoring and Resource Unit, aimed to ensure that patients and their families know about the revised maximum retail prices (MRP).
The campaign took place under the leadership of Deputy Drugs Controller Subrata Das and the initiative of the Office of the Deputy Drugs Controller, Government of Tripura.
Officials visited pharmacies across the town and displayed awareness posters to highlight the price reductions. The campaign sought to spread information about the lower prices and encourage consumers to benefit from the revised rates.
Pharmacy Campaign Focuses on Cancer Medicine Price Cuts
A representative team from the Tripura State Pharmaceutical Price Monitoring and Resource Unit visited medicine shops throughout Teliamura on Tuesday evening.
The officials informed pharmacy owners and staff about the reduction in the MRP of several cancer medicines. They also displayed posters at individual shops to make the information accessible to consumers.
The campaign focused on taking the message directly to medicine retailers, who play an important role in informing patients about medicine prices.
The initiative also aimed to raise public awareness about the government’s efforts to make cancer medicines more affordable.
Certain Cancer Medicines See MRP Reduction of 96.45%
Speaking during an interaction, Deputy Drugs Controller Subrata Das said cancer medicines would now be available at substantially lower prices.

He explained that the high cost of cancer medicines had previously made several treatments difficult to afford for ordinary families. The latest price reductions are expected to ease some of this financial burden.
According to Das, the MRP of certain cancer medicines has been reduced by as much as 96.45 per cent.
He said the reduction would make several medicines considerably more affordable and improve their accessibility for patients.
Price Cuts Expected to Save Patients Rs 3,540 Crore Annually
Das also highlighted the expected financial benefits of the revised medicine prices.
According to him, patients are expected to save around Rs 3,540 crore every year following the reduction in cancer medicine prices.
He said the government’s initiative would provide significant relief to patients and their families, particularly those facing the high costs associated with cancer treatment.
The substantial reduction in the MRP of certain medicines could help reduce treatment-related expenses for patients who depend on these drugs.
Posters Displayed Across Teliamura Pharmacies
Besides interacting with medicine retailers, the visiting team used posters to communicate the price reductions to the public.
The officials displayed posters at pharmacies across Teliamura to ensure that consumers received information about the revised MRPs.
The awareness campaign aimed to bridge the information gap between the price reductions and the people who need these medicines. By reaching pharmacies directly, the department sought to make retailers and consumers aware of the lower prices.
The initiative underlined the importance of public awareness in ensuring that patients benefit from reduced medicine costs.
